ProNAi Therapeutics, Inc. (Nasdaq: DNAI), a clinical-stage oncology company pioneering a novel class of therapeutics based on its proprietary DNAi ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE